mepenzolate has been researched along with Acute Disease in 1 studies
mepenzolic acid: anticholinergic, antispasmodic agent; RN given refers to parent cpd; structure
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventy adults in the United States with acute diarrhea who were attending classes in Guadalajara, Mexico, enrolled in a double-blind placebo-controlled treatment study of an anticholinergic drug, mepenzolate bromide (MZB)." | 5.05 | Failure to demonstrate effectiveness of an anticholinergic drug in the symptomatic treatment of acute travelers' diarrhea. ( Bass, P; DuPont, HL; Mendiola, J; Reves, R; Sullivan, P, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reves, R | 1 |
| Bass, P | 1 |
| DuPont, HL | 1 |
| Sullivan, P | 1 |
| Mendiola, J | 1 |
1 trial available for mepenzolate and Acute Disease
| Article | Year |
|---|---|
Failure to demonstrate effectiveness of an anticholinergic drug in the symptomatic treatment of acute travelers' diarrhea.
Topics: Acute Disease; Adolescent; Adult; Benzilates; Clinical Trials as Topic; Diarrhea; Double-Blind Metho | 1983 |